We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Illumina Announces LIFE & BRAIN as Germany's First Certified Genetic Analysis Service Provider

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Illumina, Inc. has announced that LIFE & BRAIN is the first company in Germany to become an Illumina CSPro® (certified service provider). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of quality data available for genetic analysis applications.

LIFE & BRAIN offers its customers whole-genome genotyping services using Illumina's Infinium® Assay. The Infinium HD (High-Density) product line provides researchers with the ability to perform large-scale interrogation of the human genome to cost-effectively fast forward their research and identify genetic variants linked to disease.

"Our mission is to delineate the molecular pathogenesis of common diseases and to develop specific diagnostic and therapeutic tools," said Sven Cichon, Ph.D., Head of the Molecular Genetics Laboratory at LIFE & BRAIN. "By becoming an Illumina CSPro, we are demonstrating our commitment to our customers by offering them access to the highest quality genetic analysis services."

Illumina CSPro participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.

"Interest in the Illumina CSPro program continues to grow with almost 20 academic and commercial technology providers already certified or in the process of certification. Now that LIFE & BRAIN is a partner, we are excited to work with them to make it easier for researchers in Germany to access the power of Illumina's genetic analysis technologies," said Karen Possemato, Director of Corporate Marketing at Illumina.